Sign In

Debbie Warner

Vice President Commercial Strategy Consulting at Kantar Health Division

Debbie Warner is a seasoned pharmaceutical industry professional with extensive experience in market access and commercial strategy, particularly in oncology. She currently holds the position of Vice President Commercial Strategy Consulting at Cerner Enviza.3 Previously, Warner served as Vice President of Oncology Commercial Strategy at Kantar Health.23

Throughout her career, Warner has held leadership roles at prominent organizations in the pharmaceutical sector, including AstraZeneca and Merck. Her expertise spans various areas, including:

  1. Market access for pharmaceuticals4
  2. Oncology commercial strategies2
  3. Pricing and reimbursement models for innovative therapies15

Warner is known for her analytical skills and insights into pharmaceutical market dynamics.4 She has contributed to discussions on finding appropriate reimbursement models for gene therapies, addressing funding challenges, and demonstrating their value.1

In her role at Kantar Health, Warner led the Oncology Commercial Strategies team, providing valuable information and strategic guidance to clients in the pharmaceutical industry.2 Her work has involved developing new approaches for identifying optimal pricing and market access strategies, particularly in the oncology sector.5

Highlights

Jul 23 · pharmaphorum.com
Finding the right reimbursement model for gene therapies

Related Questions

What are some of Debbie Warner's key achievements at Kantar?
How has Debbie Warner contributed to the field of gene therapies?
What strategies does Debbie Warner recommend for overcoming funding challenges in gene therapies?
What is Debbie Warner's background before joining Kantar?
How has Debbie Warner's role evolved at Kantar over the years?
Debbie Warner
Add to my network

Location

West Chester, Pennsylvania, United States